Sildenafil Research Overview
Vega Oral Jelly 100mg is a sildenafil citrate compound manufactured by Signature Pharmaceuticals for laboratory investigation purposes. This phosphodiesterase-5 (PDE5) inhibitor serves as a reference standard for researchers studying vascular biochemistry and cyclic guanosine monophosphate (cGMP) pathway modulation. The oral jelly formulation provides enhanced bioavailability characteristics compared to traditional tablet forms, making it valuable for pharmacokinetic research applications. Scientists at Stroid UK Shop utilize this compound to examine endothelial function and smooth muscle relaxation mechanisms in controlled laboratory environments.
Laboratory Research Applications
Research teams investigate Vega Oral Jelly’s molecular interactions with PDE5 enzymes to understand vascular physiological pathways. The compound’s mechanism involves selective inhibition of phosphodiesterase-5, preventing degradation of cGMP and maintaining elevated intracellular levels. This makes it particularly useful for studies examining nitric oxide signalling pathways and endothelium-dependent vasodilation responses. Cardiovascular researchers also explore its effects on pulmonary arterial pressure modulation and hemodynamic parameters. The jelly formulation allows for precise dissolution studies and absorption kinetic analysis. Many laboratories studying erectile dysfunction compounds use this preparation for comparative efficacy investigations alongside other research chemicals available through specialized suppliers offering SARMs and peptide research materials.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Sildenafil Citrate |
| Concentration | 100mg per unit |
| Formulation | Oral Jelly |
| Manufacturer | Signature Pharmaceuticals Ltd. |
| CAS Number | 171599-83-0 |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Storage Requirements | Room temperature, dry conditions |
| Research Applications | PDE5 inhibition studies, vascular research |
Research Compliance Notice
Vega Oral Jelly 100mg is supplied exclusively for in-vitro laboratory research purposes and scientific investigation. This compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper laboratory protocols, safety measures, and regulatory compliance when handling this material. All studies should be conducted under appropriate institutional oversight with proper documentation and waste disposal procedures. This product is restricted to qualified research facilities and personnel with appropriate training in handling pharmaceutical research compounds for scientific analysis only.
